The IMNOVID brand, founded in 2011 (United States), from 126 sister brands and 17477 competing brands. IMNOVID is owned by Celgene, listed on the stock exchange of New York IMNOVID is part of the Drug Manufacturers activity sector.

IMNOVID is a brand of Celgene () Share price

Share price and profitability of the share Celgene (IMNOVID)

Buy Celgene share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history Celgene (IMNOVID)